Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma

NCT ID: NCT07127614

Last Updated: 2025-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-10

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the diagnostic accuracy of preoperative MRI in the determination of the primary tumor depth of invasion (DOI) as a predictor factor in neck lymph nodes management in T1T2N0 oral cavity squamous cell carcinomas as compared to the pathological depth of invasion

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A diagnostic accuracy study comparing preoperative MRI scans to pathological examination of the resected oral squamous cell carcinoma with lymph nodes to determine the depth of invasion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Squamous Cell Carcinoma Mouth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

Patients with biopsy proven oral squamous cell carcinoma with the edition T1or T2 N0 based on TNM staging by American Joint cancer center AJCC 8th edition

MRI

Intervention Type DIAGNOSTIC_TEST

pre-operative MRI scan

Histo-Pathological examination of the resected tumor tissues

Intervention Type DIAGNOSTIC_TEST

histo-pathological examination of the resected tumor tissues with the lymph nodes involved to determine the pathological depth of invasion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI

pre-operative MRI scan

Intervention Type DIAGNOSTIC_TEST

Histo-Pathological examination of the resected tumor tissues

histo-pathological examination of the resected tumor tissues with the lymph nodes involved to determine the pathological depth of invasion

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

index test Reference test

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with biopsy-proven oral squamous cell carcinoma with the edition T1or T2 N0 based on TNM staging by the American Joint Cancer Center AJCC 8th edition
* The primary tumor has a depth of invasion (DOI) greater than 4 mm
* Clinical N0 status confirmed by reasonable parameters includes computed tomography CT, MRI, -Ultrasonography,( US fine needle aspiration in suspected lymph nodes )
* The primary tumor must be reliably resected to a clear margin without the need for entry of the neck for reconstruction

Exclusion Criteria

* Patients with T3T4 OCSCC
* Proven or suspected positive neck node
* Patient with distant metastasis
* Patient with gross injury to the neck that precludes proper surgical dissection.
* Patient with a history of radiotherapy to the neck
* Recurrent cases of OCSCC or recurrent node disease
* Patient with previous neck node biopsy or previous neck dissection
* Patient with a medical condition or performance that interferes with the surgical intervention as judged by the specialist physician
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Islam Mohamed Mohamed Ali

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wael A ElMohandes, PhD

Role: STUDY_DIRECTOR

oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University

Ahmed M Alfar, PhD

Role: STUDY_CHAIR

oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University

Mohamed A Mohamed, PhD

Role: STUDY_CHAIR

oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University

Mohamed AW Amin, PhD

Role: STUDY_CHAIR

oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AL Sayed Galal Hospital Al-Azhar University

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Islam M Ali, MSc

Role: CONTACT

+201274454102

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Islam M Ali

Role: primary

+201274454102

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1008/2042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.